Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Northeastern University, Department of Pharmaceutical Sciences details research in cancer gene therapy
February 3rd, 2009
A report, 'Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells,' is newly published data in The Aaps Journal [electronic Resource]. "Type B gelatin-based engineered nanocarrier systems (GENS) have been used over the last several years as a non-condensing systemic and oral DNA delivery system. In this study, we have modified the surface of GENS with epidermal growth factor receptor (EGFR)-targeting peptide for gene delivery and transfection in pancreatic cancer cell lines," researchers in the United States report. "GENS were prepared by the solvent displacement method...
Source: Cancer Weekly (2009-02-03)
|
